![Humphrey Gardner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Humphrey Gardner
Corporate Officer/Principal chez
American Society of Clinical Oncology, Inc.
Profil
Humphrey A. R.
Gardner currently works at American Society of Clinical Oncology, Inc., as Member.
Dr. Gardner also formerly worked at Karyopharm Therapeutics, Inc., as Senior Vice President-Clinical Development, Evelo Biosciences, Inc., as Chief-Medical Oncology, Silicon Insite, Inc., as Chief Medical Officer, Harbour BioMed (Shanghai) Co., Ltd., as Chief Medical Officer, Medicenna Therapeutics Corp., as Global Chief Medical Officer from 2023 to 2024, and HBM Holdings Ltd., as Chief Medical Officer.
Dr. Gardner received his undergraduate degree and doctorate degree from the University of Cambridge and graduate degree from Brandeis University.
Postes actifs de Humphrey Gardner
| Sociétés | Poste | Début |
|---|---|---|
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Anciens postes connus de Humphrey Gardner
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur Technique/Scientifique/R&D | 14/02/2024 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Directeur Technique/Scientifique/R&D | - |
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Directeur Technique/Scientifique/R&D | - |
| HBM HOLDINGS LIMITED | Directeur Technique/Scientifique/R&D | - |
Formation de Humphrey Gardner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
HBM Holdings Ltd.
 HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
